Luminza, Ronilo G.

HRN: 28-93-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CEFUROXIME 1.5GM (VIAL)
05/03/2026
05/10/2026
IV
1.5g
Q8h
Fracture Closed Complete Proximal 3rd Femur Sec To RCI; Fracture Closed Complete Middle 3rd Tibia And Fibula Right Sec To RCI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: